Type 1 diabetes trials in Russia
1 trial · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleImmunotherapy of the Recent-onset Type 1 Diabetes in Adolescents With Repeated Courses of Rituximab
- Where
- Moscow
- Age
- 12 years to 18 years
- People
- 116
- Run by
- Pirogov Russian National Research Medical University
See details and how to joinNCT07041268